BIODESIX INC's ticker is BDSX and the CUSIP is 09075X108. A total of 46 filers reported holding BIODESIX INC in Q2 2024. The put-call ratio across all filers is 23.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,446,951 | +284.9% | 2,906,504 | +259.7% | 0.00% | – |
| Q1 2024 | $1,155,337 | -22.6% | 807,928 | -0.5% | 0.00% | – |
| Q4 2023 | $1,493,621 | -11.4% | 811,751 | -20.6% | 0.00% | – |
| Q3 2023 | $1,686,034 | +6.1% | 1,021,839 | -20.9% | 0.00% | – |
| Q2 2023 | $1,589,700 | -30.6% | 1,292,439 | +5.0% | 0.00% | – |
| Q1 2023 | $2,289,366 | -10.0% | 1,230,842 | +11.2% | 0.00% | – |
| Q4 2022 | $2,544,726 | +734.3% | 1,106,403 | +361.7% | 0.00% | – |
| Q3 2022 | $305,000 | +3.4% | 239,656 | +33.1% | 0.00% | – |
| Q2 2022 | $295,000 | -20.7% | 179,996 | -18.2% | 0.00% | – |
| Q1 2022 | $372,000 | -81.3% | 219,953 | -41.5% | 0.00% | – |
| Q4 2021 | $1,989,000 | -35.6% | 376,090 | +0.0% | 0.00% | – |
| Q3 2021 | $3,090,000 | -35.8% | 375,958 | +3.2% | 0.00% | – |
| Q2 2021 | $4,810,000 | -11.8% | 364,135 | +35.7% | 0.00% | – |
| Q1 2021 | $5,451,000 | +17.7% | 268,378 | +16.8% | 0.00% | – |
| Q4 2020 | $4,632,000 | – | 229,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,370,071 | $3,010,000 | 2.12% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 378,023 | $480,000 | 0.08% |
| Endurant Capital Management LP | 130,136 | $165,000 | 0.05% |
| Cannell & Co. | 205,605 | $261,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $127,000 | 0.00% |
| CPWM, LLC | 15,497 | $20,000 | 0.00% |
| Allworth Financial LP | 55,853 | $71,000 | 0.00% |
| Column Capital Advisors, LLC | 5,700 | $7,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 973 | $1,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 3,004 | $3,815,000 | 0.00% |